HLA-A and cancer: KRAS is one of the human cancers' most common mutant proto‐oncogenes, occurring in the single amino acid at codon 12.[75, 76] Based on HLA‐peptide prediction algorithms, HLA‐A * 11: 01 can effectively deliver antigens derived from KRAS mutated variants to specific T cells.